Correlation Between Take Two and CRISPR Therapeutics

Can any of the company-specific risk be diversified away by investing in both Take Two and CRISPR Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Take Two and CRISPR Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Take Two Interactive Software and CRISPR Therapeutics AG, you can compare the effects of market volatilities on Take Two and CRISPR Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Take Two with a short position of CRISPR Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Take Two and CRISPR Therapeutics.

Diversification Opportunities for Take Two and CRISPR Therapeutics

0.53

Correlation Coefficient

Take Two  CRISPR Therapeutics

Very weak diversification

The 3 months correlation between Take and CRISPR is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Take Two Interactive Software and CRISPR Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CRISPR Therapeutics and Take Two is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Take Two Interactive Software are associated (or correlated) with CRISPR Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CRISPR Therapeutics has no effect on the direction of Take Two i.e., Take Two and CRISPR Therapeutics go up and down completely randomly.

Pair Corralation between Take Two and CRISPR Therapeutics

Assuming the 90 days trading horizon Take Two Interactive Software is expected to generate 0.62 times more return on investment than CRISPR Therapeutics. However, Take Two Interactive Software is 1.61 times less risky than CRISPR Therapeutics. It trades about 0.05 of its potential returns per unit of risk. CRISPR Therapeutics AG is currently generating about -0.31 per unit of risk. If you would invest  28,600  in Take Two Interactive Software on October 8, 2024 and sell it today you would earn a total of  474.00  from holding Take Two Interactive Software or generate 1.66% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	94.12%
Values	Daily Returns

Take Two Interactive Software  vs.  CRISPR Therapeutics AG

Take Two Interactive

Risk-Adjusted Performance

24 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Take Two Interactive Software are ranked lower than 24 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Take Two sustained solid returns over the last few months and may actually be approaching a breakup point.

CRISPR Therapeutics

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in CRISPR Therapeutics AG are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, CRISPR Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Take Two and CRISPR Therapeutics

The main advantage of trading using opposite Take Two and CRISPR Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Take Two position performs unexpectedly, CRISPR Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CRISPR Therapeutics will offset losses from the drop in CRISPR Therapeutics' long position.

The idea behind Take Two Interactive Software and CRISPR Therapeutics AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.